Voice-Activated Cognitive Behavioral Therapy for Insomnia: A Randomized Clinical Trial
Practical Solutions and Value Highlights:
Insomnia Impact: Insomnia affects 30-50% of US breast cancer survivors.
Objective: To test a voice-activated CBT-I program for improving insomnia in survivors.
Participants: Breast cancer survivors with insomnia were recruited from various groups.
Intervention: Participants received either a voice-interactive CBT-I program or educational control for 6 weeks.
Outcomes: The CBT-I program significantly improved insomnia symptoms and sleep quality.
Conclusion: The study showed the effectiveness of the voice-activated CBT-I program for breast cancer survivors.
Practical Value: The program could be scaled up and integrated into routine care for broader impact.
Value of Clinical Trials:
Clinical trials are crucial for developing safe treatments and integrating them into medical practice.
AI-Driven Solutions:
DocSym’s AI platform consolidates standards and research for easy access by clinicians.
Mobile apps by DocSym support scheduling, monitoring treatments, and telemedicine for efficient patient care.
AI implementation in clinics can enhance workflows, improve outcomes, and reduce paperwork.
Explore more about our solutions at aidevmd.com.
